Table 1 of Tariq, Mol Vis 2013; 19:710-717.


Table 1. Genotype and allele frequency distribution of Pro12Ala polymorphism of PPARγ among DR, DNR, and control groups.

Overall Controls DR DNR DR versus Controls DR versus DNR DNR versus Controls
n=200 n=180 n=193 χ2 (p) OR(95%CI) χ2 (p) OR(95%CI) χ2 (p) OR(95%CI)
Pro/Pro 155(77.5%) 149(82.8%) 143(74.1%) 3.02 DM=0.72(0.42–1.23) 9.34 DM=0.6(0.35–1.01) 3.97 DM=1.2(0.76–1.91)
Pro/Ala 43(21.5%) 31(17.2%) 42(21.8%) (0.22) (0.01) (0.14)
Ala/Ala 2(1%) 0 8(4.2%)
Pro 353(88%) 329(91.4%) 328(85%) 2.03 0.71(0.43–1.17) 7.3 0.53(0.33–0.87) 1.82 1.33(0.86–2.05)
Ala 47(12%) 31(8.6%) 58(15%) (0.15) (0.01) (0.18)
Males n=100 n=87 n=94
Pro/Pro 81(81%) 69(79.3%) 68(72.3%) 2.09 DM=1.11(0.51–2.42) 5.85 DM=0.68(0.32–1.43) 3.19 DM=1.63(0.79–3.38)
Pro/Ala 17(17%) 18(20.7%) 20(21.3%) (0.35) (0.05) (0.2)
Ala/Ala 2(2%) 0 6(6.4%)
Pro 179(89.5%) 156(89.7%) 156(83%) 0.00 0.98(0.48–2.01) 3.38 0.56(0.29–1.09) 3.49 1.75(0.93–3.29)
Ala 21(10.5%) 18(10.3%) 32(17%) (0.96) (0.07) (0.06)
Females n=100 n=93 n=99
Pro/Pro 74(74%) 80(86%) 75(75.8%) 4.32 DM=0.48(0.23–1.05) 4.29 DM=0.51(0.23–1.13) 2.34 DM=0.91(0.46–1.8)
Pro/Ala 26(26%) 13(14%) 22(22.2%) (0.04) (0.12) (0.31)
Ala/Ala 0 0 2(2%)
Pro 174(87%) 173(93%) 172(87%) 3.83 0.52(0.24–1.06) 3.97 0.5(0.23–1.05) 0.00 1.01(0.54–1.88)
Ala 26(13%) 13(7%) 26(13%) (0.05) (0.05) (0.97)